U.S. Food and Drug Administration Inspections of Clinical Investigators: Overview of Results from 1977 to 2009 | Citedby Results | Clinical Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

U.S. Food and Drug Administration Inspections of Clinical Investigators: Overview of Results from 1977 to 2009

Clin Cancer Res (2014) 20 (13): 3364–3370.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices

David J. Stewart
John-Peter Bradford
Sandeep Sehdev
Tim Ramsay
Vishal Navani
Nigel S. B. Rawson
Di Maria Jiang
Joanna Gotfrit
Paul Wheatley-Price
Geoffrey Liu
Alan Kaplan
Silvana Spadafora
Shaun G. Goodman
Rebecca A. C. Auer
Gerald Batist

Current Oncology (2024) 31 (5): 2453.

Practical Guidelines for Standardised Resolution of Important Protocol Deviations in Clinical Trials Conducted in Sub-Saharan Africa

Armel Zemsi
Lorraine Jinette Guedem Nekame
Nuredin Mohammed
Elizabeth Stanley Batchilly
Edgard Dabira
Sheikh Omar Sillah
Gibbi Sey
Daisy H. Williams
Bai-Lamin Dondeh
Carla Cerami
Ed Clarke
Umberto D’Alessandro

Therapeutic Innovation & Regulatory Science (2024) 58 (3): 395.

Blockchain Applications in Health Care and Public Health: Increased Transparency

Pedro Elkind Velmovitsky
Frederico Moreira Bublitz
Laura Xavier Fadrique
Plinio Pelegrini Morita

JMIR Medical Informatics (2021) 9 (6): e20713.

A Blockchain-Based Consent Platform for Active Assisted Living: Modeling Study and Conceptual Framework

Pedro Elkind Velmovitsky
Pedro Augusto Da Silva E Souza Miranda
Hélène Vaillancourt
Tania Donovska
Jennifer Teague
Plinio Pelegrini Morita

Journal of Medical Internet Research (2020) 22 (12): e20832.

Clinical Investigator Training Program (CITP) – A practical and pragmatic approach to conveying clinical investigator competencies and training to busy clinicians

Mansoor Saleh
Gurudatta Naik
Penelope Jester
Cynthia Joiner
Elizabeth Westfall
David W. Kimberlin
James Willig
David Redden
Juliette Southworth
Mark T. Dransfield

Contemporary Clinical Trials Communications (2020) 19: 100589.

Research Deviations in FDA-Regulated Clinical Trials: A Cross-Sectional Analysis of FDA Inspection Citations

Craig A. Garmendia
Katrina Epnere
Neera Bhansali

Therapeutic Innovation & Regulatory Science (2018) 52 (5): 579.

Blockchain protocols in clinical trials: Transparency and traceability of consent

Mehdi Benchoufi
Raphael Porcher
Philippe Ravaud

F1000Research (2018) 6: 66.

‘Screening audit’ as a quality assurance tool in good clinical practice compliant research environments

Sinyoung Park
Chung Mo Nam
Sejung Park
Yang Hee Noh
Cho Rong Ahn
Wan Sun Yu
Bo Kyung Kim
Seung Min Kim
Jin Seok Kim
Sun Young Rha

BMC Medical Ethics (2018) 19 (1)

A Retrospective Analysis of Clinical Research Misconduct Using FDA-Issued Warning Letters and Clinical Investigator Inspection List From 2010 to 2014

Christopher A. Romano
Singh Nair
Ellise S. Delphin

Anesthesia & Analgesia (2018) 126 (3): 976.

Blockchain protocols in clinical trials: Transparency and traceability of consent

Mehdi Benchoufi
Raphael Porcher
Philippe Ravaud

F1000Research (2017) 6: 66.

The Urgent Need for Clinical Research Reform to Permit Faster, Less Expensive Access to New Therapies for Lethal Diseases

David J. Stewart
Gerald Batist
Hagop M. Kantarjian
John-Peter Bradford
Joan H. Schiller
Razelle Kurzrock

Clinical Cancer Research (2015) 21 (20): 4561.